Actavis announces acquisition of Silom Medical for $100 million Actavis plc.

We needed new efficiency within IMRT plan evaluation, deformable registration and multi-criteria optimization. We found RayStation to end up being the operational system to meet our needs, both in today’s and future considerations,’ says Dr. James Gerstley, Radiation Oncologist and Co-Director at Advanced ROS. Our cutting edge technology compliments a center that offers regional patients the best standard of care with leading technology.’ ‘Advanced ROS gives a top-notch treatment group and we have become excited to put into action our systems within a center with skilled personnel and innovative technology,’ concludes Marc Mlyn, President of RaySearch Americas..Samples were delivered to the Ariosa scientific laboratory, that is certified according to the Clinical Laboratory Improvement Amendments, without further processing. Outcomes for cfDNA testing were not open to participants or providers. Testing Methods All patients underwent regular screening by using local laboratories. All suppliers of nuchal translucency were qualified by the Nuchal Translucency Quality Review program, the Fetal Medicine Base, or other national quality-review programs. All measurements of nuchal translucency were performed and serum samples gathered within the gestational a long time required by the local laboratory. For scientific risk assessment, we used local risk algorithms and cutoffs regarding to standard medical practice.